Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$31 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$-25 Mln
ROE
-1.9 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.8
Industry P/E
20.97
EV/EBITDA
-0.7
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-2.3
Face value
--
Shares outstanding
4,973,690
CFO
$-162.76 Mln
EBITDA
$-194.62 Mln
Net Profit
$-198.24 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Calyxt (CLXT)
| 164.5 | 50.3 | 23.9 | 70.2 | -55.4 | -53.3 | -- |
|
BSE Sensex*
| -12.5 | -7.4 | -13.3 | -1.7 | 7.5 | 8.6 | 11.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|
|
Calyxt (CLXT)
| -93.1 | -49.5 | -39.8 | -32.3 | -52.8 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Calyxt (CLXT)
|
19.5 | 31.3 | 0.3 | -32.7 | -10,164.7 | -14 | -- | 0.8 |
| 18.1 | 3,801.7 | 7,291.0 | 649.0 | 15.8 | -48.7 | 6 | 1,403.4 | |
| 26.5 | 11,196.1 | 12,601.5 | 222.8 | 2.1 | 58.7 | 51.7 | 22.3 | |
| 63.2 | 3,647.4 | 1,519.8 | 103.9 | 11.5 | 10.6 | 34.6 | 3.2 | |
| 24.8 | 1,881.9 | 1,987.5 | 29.6 | 3.0 | 3.5 | 64 | 2.2 | |
| 26.4 | 730.4 | 1,336.2 | 47.8 | 4.7 | 22.6 | 16.9 | 2.7 | |
| 2.7 | 762.1 | 5,961.5 | 9.1 | 2.1 | 0.8 | 89.3 | 0.7 | |
| 26.7 | 1,492.4 | 4,101.7 | -45.8 | 2.5 | 6.5 | 127.5 | 2.5 | |
| 13.4 | 1,306.0 | 3,706.7 | 180.4 | 8.3 | 22.7 | 7.6 | 1.6 | |
| 421.9 | 1,539.8 | 86.1 | 41.7 | 64.6 | -79.5 | 38 | 40.7 |
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a... higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Read more
Pres, CEO & Director
Mr. Michael Allen Carr
Pres, CEO & Director
Mr. Michael Allen Carr
Headquarters
Roseville, MN
Website
The share price of Calyxt Inc (CLXT) is $19.51 (NASDAQ) as of 02-Aug-2023 09:30 EDT. Calyxt Inc (CLXT) has given a return of -55.44% in the last 3 years.
Since, TTM earnings of Calyxt Inc (CLXT) is negative, P/E ratio is not available.
The P/B ratio of Calyxt Inc (CLXT) is 0.85 times as on 02-Aug-2023, a 73 discount to its peers’ median range of 3.17 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.73
|
0.99
|
|
2021
|
-2.80
|
5.77
|
|
2020
|
-3.30
|
4.15
|
|
2019
|
-5.63
|
3.70
|
|
2018
|
-12.14
|
3.62
|
The 52-week high and low of Calyxt Inc (CLXT) are Rs -- and Rs -- as of 07-Apr-2026.
Calyxt Inc (CLXT) has a market capitalisation of $ 31 Mln as on 02-Aug-2023. As per SEBI classification, it is a company.
Before investing in Calyxt Inc (CLXT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.